Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?

× No keyword cloud information.

10 in total

1. METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS.

Authors: R L BLACK; W M O'BRIEN; E J VANSCOTT; R AUERBACH; A Z EISEN; J J BUNIM
Journal: JAMA Date: 1964-09-07 Impact factor: 56.272

Review 2. Use of methotrexate in patients with psoriatic arthritis.

Authors: A Ceponis; A Kavanaugh
Journal: Clin Exp Rheumatol Date: 2010-10-28 Impact factor: 4.473

Review 3. Psoriatic arthritis: update on pathophysiology, assessment and management.

Authors: Philip J Mease
Journal: Ann Rheum Dis Date: 2011-03 Impact factor: 19.103

4. Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis.

Authors: R F Willkens; H J Williams; J R Ward; M J Egger; J C Reading; P J Clements; E S Cathcart; C O Samuelson; M A Solsky; S B Kaplan
Journal: Arthritis Rheum Date: 1984-04

5. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate.

Authors: David Kane; Martina Gogarty; John O'leary; Ivan Silva; Niamh Bermingham; Barry Bresnihan; Oliver Fitzgerald
Journal: Arthritis Rheum Date: 2004-10

Review 6. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI).

Authors: Philip J Mease
Journal: Arthritis Care Res (Hoboken) Date: 2011-11 Impact factor: 4.794

7. Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort.

Authors: Vinod Chandran; Catherine T Schentag; Dafna D Gladman
Journal: J Rheumatol Date: 2007-12-15 Impact factor: 4.666

8. Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.

Authors: Asta Baranauskaite; Helena Raffayová; N V Kungurov; Anna Kubanova; Algirdas Venalis; Laszlo Helmle; Shankar Srinivasan; Evgeny Nasonov; Nathan Vastesaeger
Journal: Ann Rheum Dis Date: 2011-10-12 Impact factor: 19.103

9. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.

Authors: Gabrielle H Kingsley; Anna Kowalczyk; Helen Taylor; Fowzia Ibrahim; Jonathan C Packham; Neil J McHugh; Diarmuid M Mulherin; George D Kitas; Kuntal Chakravarty; Brian D M Tom; Aidan G O'Keeffe; Peter J Maddison; David L Scott
Journal: Rheumatology (Oxford) Date: 2012-02-17 Impact factor: 7.580

Review 10. Treatment recommendations for psoriatic arthritis.

Authors: C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal: Ann Rheum Dis Date: 2008-10-24 Impact factor: 19.103

10 in total

9 in total

Review 1. Psoriatic arthritis: latest treatments and their place in therapy.

Authors: Eun Jin Kang; Arthur Kavanaugh
Journal: Ther Adv Chronic Dis Date: 2015-07 Impact factor: 5.091

2. SEAM-PsA: Seems Like Methotrexate Works in Psoriatic Arthritis?

Authors: Joseph F Merola; Alexis Ogdie
Journal: Arthritis Rheumatol Date: 2019-07 Impact factor: 10.995

Review 3. Advances in the management of psoriatic arthritis.

Authors: Ignazio Olivieri; Salvatore D'Angelo; Carlo Palazzi; Angela Padula
Journal: Nat Rev Rheumatol Date: 2014-07-08 Impact factor: 20.543

Review 4. Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis.

Authors: Philip J Mease
Journal: Rheumatol Ther Date: 2014-12-09

Review 5. Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis.

Authors: Martin Bergman; Amy Lundholm
Journal: Arthritis Res Ther Date: 2017-03-20 Impact factor: 5.156

6. Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Authors: Gia Deyab; Ingrid Hokstad; Jon Elling Whist; Milada Cvancarova Småstuen; Stefan Agewall; Torstein Lyberg; Barbara Bottazzi; Pier Luigi Meroni; Roberto Leone; Gunnbjorg Hjeltnes; Ivana Hollan
Journal: PLoS One Date: 2017-02-22 Impact factor: 3.240

7. Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA).

Authors: Philip J Mease; Dafna D Gladman; Ahmed S Samad; Laura C Coates; Lyrica X H Liu; Girish A Aras; David H Collier; James B Chung
Journal: RMD Open Date: 2018-02-03

Review 8. Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis.

Authors: Xing Lyu; Jieli Chen; Xingjie Gao; Jie Yang
Journal: Front Cell Infect Microbiol Date: 2022-08-22 Impact factor: 6.073

9. Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registry.

Authors: Philip J Mease; David H Collier; Katherine C Saunders; Guo Li; Joel M Kremer; Jeffrey D Greenberg
Journal: RMD Open Date: 2015-12-30

9 in total